University of Texas/Texas AM Investment Management Co (UTIMCO)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,322	Closed	-$166K	–	85
2017 Q3	$166K	Buy	+5,322	New	+$160K	0.4%	18
2017 Q1	–	Sell	-22,747	Closed	-$497K	–	41
2016 Q4	$497K	Sell	22,747 -5,846	-20%	-$148K	1.43%	13
2016 Q3	$754K	Buy	28,593 +27,434	+2,367%	+$544K	2.01%	13
2016 Q2	$23K	Buy	+1,159	New	+$22.5K	0.07%	17

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s RETA Position: Q4 2017 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2017, closing a stake of 5,322 shares — an estimated $166K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in RETA in Q2 2016 and held it in 4 quarters. The position peaked at $754K in Q3 2016. 89 funds tracked by Wall St. Rank hold RETA as of Q4 2017.

University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
University of Texas/Texas AM Investment Management Co (UTIMCO) sold 5,322 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2017, an estimated $166K.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 4 quarters.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $754K in Q3 2016.
89 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2017.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2017, filed 8 Feb 2018.